| Term | Count | % | | TREATMENT FAILURE | 5888 | 7.61% |
| DRUG INEFFECTIVE | 2978 | 3.85% |
| EYE IRRITATION | 2271 | 2.93% |
| FATIGUE | 1955 | 2.53% |
| INTRAOCULAR PRESSURE INCREASED | 1802 | 2.33% |
| EYE PAIN | 1555 | 2.01% |
| HEADACHE | 1543 | 1.99% |
| DYSPNOEA | 1509 | 1.95% |
| DEATH | 1496 | 1.93% |
| VISION BLURRED | 1481 | 1.91% |
| DIZZINESS | 1471 | 1.90% |
| DIARRHOEA | 1423 | 1.84% |
| NAUSEA | 1403 | 1.81% |
| CATARACT | 1344 | 1.74% |
| OFF LABEL USE | 1342 | 1.73% |
| OCULAR HYPERAEMIA | 1331 | 1.72% |
| FALL | 1317 | 1.70% |
| GLAUCOMA | 1311 | 1.69% |
| ASTHENIA | 1144 | 1.48% |
| HYPERSENSITIVITY | 1133 | 1.46% |
| PAIN | 1128 | 1.46% |
| MALAISE | 960 | 1.24% |
| VISUAL IMPAIRMENT | 938 | 1.21% |
| PNEUMONIA | 908 | 1.17% |
| RASH | 891 | 1.15% |
| PRURITUS | 855 | 1.10% |
| ARTHRALGIA | 827 | 1.07% |
| WEIGHT DECREASED | 823 | 1.06% |
| CONDITION AGGRAVATED | 815 | 1.05% |
| PAIN IN EXTREMITY | 802 | 1.04% |
| COUGH | 799 | 1.03% |
| HYPERTENSION | 797 | 1.03% |
| VOMITING | 787 | 1.02% |
| EYE PRURITUS | 750 | 0.97% |
| DRUG HYPERSENSITIVITY | 734 | 0.95% |
| VISUAL ACUITY REDUCED | 725 | 0.94% |
| CONSTIPATION | 665 | 0.86% |
| DRY EYE | 664 | 0.86% |
| EYE DISORDER | 641 | 0.83% |
| INSOMNIA | 641 | 0.83% |
| PYREXIA | 606 | 0.78% |
| CONFUSIONAL STATE | 597 | 0.77% |
| BACK PAIN | 574 | 0.74% |
| DECREASED APPETITE | 572 | 0.74% |
| PRODUCT QUALITY ISSUE | 569 | 0.74% |
| ACUTE KIDNEY INJURY | 560 | 0.72% |
| DEPRESSION | 559 | 0.72% |
| PRODUCT DOSE OMISSION ISSUE | 553 | 0.71% |
| URINARY TRACT INFECTION | 534 | 0.69% |
| CEREBROVASCULAR ACCIDENT | 530 | 0.68% |
| ANAEMIA | 525 | 0.68% |
| GAIT DISTURBANCE | 516 | 0.67% |
| INCORRECT DOSE ADMINISTERED | 503 | 0.65% |
| CHEST PAIN | 493 | 0.64% |
| FEELING ABNORMAL | 493 | 0.64% |
| SOMNOLENCE | 493 | 0.64% |
| BLOOD PRESSURE INCREASED | 491 | 0.63% |
| HYPOTENSION | 485 | 0.63% |
| ANXIETY | 480 | 0.62% |
| ERYTHEMA | 476 | 0.62% |
| LACRIMATION INCREASED | 463 | 0.60% |
| BLINDNESS | 453 | 0.59% |
| PALPITATIONS | 438 | 0.57% |
| MYALGIA | 437 | 0.56% |
| DRUG INTOLERANCE | 427 | 0.55% |
| RENAL FAILURE | 424 | 0.55% |
| ATRIAL FIBRILLATION | 423 | 0.55% |
| COVID-19 | 416 | 0.54% |
| MUSCLE SPASMS | 416 | 0.54% |
| HAEMOGLOBIN DECREASED | 408 | 0.53% |
| PERIPHERAL SWELLING | 407 | 0.53% |
| PRODUCT USE ISSUE | 405 | 0.52% |
| ABDOMINAL DISCOMFORT | 403 | 0.52% |
| OEDEMA PERIPHERAL | 403 | 0.52% |
| NASOPHARYNGITIS | 402 | 0.52% |
| TREMOR | 402 | 0.52% |
| ABDOMINAL PAIN | 381 | 0.49% |
| BRONCHITIS | 380 | 0.49% |
| ALOPECIA | 378 | 0.49% |
| DEHYDRATION | 370 | 0.48% |
| ABDOMINAL PAIN UPPER | 369 | 0.48% |
| ARTHRITIS | 361 | 0.47% |
| MUSCULAR WEAKNESS | 361 | 0.47% |
| WEIGHT INCREASED | 358 | 0.46% |
| EYE SWELLING | 353 | 0.46% |
| MYOCARDIAL INFARCTION | 353 | 0.46% |
| PRODUCT USE IN UNAPPROVED INDICATION | 352 | 0.45% |
| FOREIGN BODY SENSATION IN EYES | 344 | 0.44% |
| SYNCOPE | 343 | 0.44% |
| MEMORY IMPAIRMENT | 340 | 0.44% |
| PARAESTHESIA | 329 | 0.43% |
| HYPOAESTHESIA | 326 | 0.42% |
| CARDIAC FAILURE CONGESTIVE | 325 | 0.42% |
| BLOOD GLUCOSE INCREASED | 322 | 0.42% |
| BALANCE DISORDER | 320 | 0.41% |
| DRUG INTERACTION | 316 | 0.41% |
| ASTHMA | 315 | 0.41% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 302 | 0.39% |
| CARDIAC DISORDER | 301 | 0.39% |
| DRUG DOSE OMISSION | 298 | 0.39% |
| Total | 77380 | |